Colin La Galia
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Colin La Galia
Managing Director / NeuroSpine Institute
Most Notable Role
Colin La Galia is a highly experienced executive in phamaceuticals, health care, devices and diagnostics, as well as business development locally and internationally.
Mr La Galia has been the managing director of NeuroSpine Institute since June 2023. Prior to that, he was the senior business advisor and general manager for Australia at InstaMed, chief commercial officer at technology firm DUG, and chief executive of Epichem from October 2019 to March 2022. He was also the regional business director and commercial head of Asia Pacific, China and Japan for Abbott Rapid Diagnostics; and held senior roles for over 20 years at Alere, Origin Healthcare, Hollywood Fertility Centre, GlaxoSmithKline and Merck Sharpe & Dohme.
Mr La Galia has been a board member of Neurospine Foundation, Avon Recovery Centre, and The Hospital Research Foundation Group. He has also been an advisory panel chair for biotech company Meliorem and STEM education service provider StemSmart, an independent expert on the Government’s ARC Panel, and a foundational committee member of Lifesciences WA.
Mr La Galia has been the managing director of NeuroSpine Institute since June 2023. Prior to that, he was the senior business advisor and general manager for Australia at InstaMed, chief commercial officer at technology firm DUG, and chief executive of Epichem from October 2019 to March 2022. He was also the regional business director and commercial head of Asia Pacific, China and Japan for Abbott Rapid Diagnostics; and held senior roles for over 20 years at Alere, Origin Healthcare, Hollywood Fertility Centre, GlaxoSmithKline and Merck Sharpe & Dohme.
Mr La Galia has been a board member of Neurospine Foundation, Avon Recovery Centre, and The Hospital Research Foundation Group. He has also been an advisory panel chair for biotech company Meliorem and STEM education service provider StemSmart, an independent expert on the Government’s ARC Panel, and a foundational committee member of Lifesciences WA.
Lists and Charts
Roles
Year started and most recent title
Person Activity
| NEWS: Tagged in Appointments November 3, 2023 | 03 Nov 2023 |
| NEW ROLE: Non-Executive Director, The Hospital Research Foundation Group Western Australia | 27 Jun 2023 |
| NEW ROLE: Managing Director, NeuroSpine Institute | 27 Jun 2023 |
| NEWS: Tagged in Funding boost an added advantage | 03 Feb 2022 |
| NEWS: Tagged in New paradigm developing in relationship between community sector, government | 03 Feb 2022 |
